The effect of SGLT2 inhibition on prostate cancer: Mendelian randomization and observational analysis using electronic healthcare and cohort data
Authors:
- Jie ZhengJZJie Zheng
- Jieli LuJLJieli Lu
- Jiying QiJQJiying Qi
- Haoyu LiuHLHaoyu Liu
- Zhihe ChenZCZhihe Chen
- Lanhui HuangLHLanhui Huang
- Min XuMXMin Xu
- Yu XuYXYu Xu
- Tiange WangTWTiange Wang
Open Access
- 20 August 2024
- journal article
- research article
- Published by Elsevier in Cell Reports Medicine
- Vol. 5 (8) , 101688
Abstract
No abstract availableKeywords
Funding Information
- Innovative Research Team of High-level Local University in Shanghai
- Cancer Research UK (C18281/A29019)
- Shanghai Shenkang Hospital Development Center (SHDC12019101, SHDC2020CR3064B, SHDC2020CR1001A)
- National Institute for Health and Care Research (NIHR202411, 15825)
- Medical Research Council (MC_UU_00032/03)
- National Key Research and Development Program of China (2022YFC2505203)
- University of Bristol
- Wellcome Trust
- British Heart Foundation
- Diabetes UK
- NIHR Bristol Biomedical Research Centre
- National Natural Science Foundation of China (82170819, 82370810, 82088102, 81970728, 81941017, 81970691, 81930021)
- Department for Business, Energy and Industrial Strategy, UK Government
- Academy of Medical Sciences
- University Hospitals Bristol NHS Foundation Trust (C68933/A28534)
This publication has 63 references indexed in Scilit:
- SGLT2 inhibitors in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials balancing their risks and benefitsDiabetologia, 2022
- Strengthening the Reporting of Observational Studies in Epidemiology Using Mendelian RandomizationJAMA, 2021
- SGLT2 and cancerPflügers Archiv - European Journal of Physiology, 2020
- Mendel’s laws, Mendelian randomization and causal inference in observational data: substantive and nomenclatural issuesEuropean Journal of Epidemiology, 2020
- Association of Lifestyle and Genetic Risk With Incidence of DementiaJAMA, 2019
- Mendelian randomization with fine‐mapped genetic data: Choosing from large numbers of correlated instrumental variablesGenetic Epidemiology, 2017
- SGLT2 inhibitors and risk of cancer in type 2 diabetes: a systematic review and meta-analysis of randomised controlled trialsDiabetologia, 2017
- A framework for the investigation of pleiotropy in two‐sample summary data Mendelian randomizationStatistics in Medicine, 2017
- Consistent Estimation in Mendelian Randomization with Some Invalid Instruments Using a Weighted Median EstimatorGenetic Epidemiology, 2016
- The Active Comparator, New User Study Design in Pharmacoepidemiology: Historical Foundations and Contemporary ApplicationCurrent Epidemiology Reports, 2015